172 related articles for article (PubMed ID: 21976631)
1. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
Mascalchi M; Mazzoni LN; Falchini M; Belli G; Picozzi G; Merlini V; Vella A; Diciotti S; Falaschi F; Lopes Pegna A; Paci E
Br J Radiol; 2012 Aug; 85(1016):1134-9. PubMed ID: 21976631
[TBL] [Abstract][Full Text] [Related]
2. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
3. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
[TBL] [Abstract][Full Text] [Related]
4. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
5. Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.
Saltybaeva N; Martini K; Frauenfelder T; Alkadhi H
PLoS One; 2016; 11(5):e0155722. PubMed ID: 27203720
[TBL] [Abstract][Full Text] [Related]
6. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
Hadique S; Jain P; Hadi Y; Baig A; Parker JE
BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
[TBL] [Abstract][Full Text] [Related]
7. Radiation Risks in Lung Cancer Screening Programs.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-624. PubMed ID: 27845636
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers.
Murano T; Tateishi U; Iinuma T; Shimada N; Daisaki H; Terauchi T; Moriyama N; Inoue T
Ann Nucl Med; 2010 May; 24(4):261-7. PubMed ID: 20237874
[TBL] [Abstract][Full Text] [Related]
9. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Screening CT: Sex-Specific Conversion Factors to Estimate Effective Radiation Dose From Dose-Length Product.
Cohen SL; Wang JJ; Chan N; O'Connell W; Shah R; Sanelli P; Raoof S
Chest; 2019 Dec; 156(6):1214-1222. PubMed ID: 31421112
[TBL] [Abstract][Full Text] [Related]
11. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
[TBL] [Abstract][Full Text] [Related]
12. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
Hendrick RE; Smith RA
Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
[TBL] [Abstract][Full Text] [Related]
13. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial.
Mascalchi M; Belli G; Zappa M; Picozzi G; Falchini M; Della Nave R; Allescia G; Masi A; Pegna AL; Villari N; Paci E
AJR Am J Roentgenol; 2006 Aug; 187(2):421-9. PubMed ID: 16861547
[TBL] [Abstract][Full Text] [Related]
14. Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.
Nishi SPE; Zhou J; Okereke I; Kuo YF; Goodwin J
Chest; 2020 Feb; 157(2):427-434. PubMed ID: 31521671
[TBL] [Abstract][Full Text] [Related]
15. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
16. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.
Huang B; Law MW; Khong PL
Radiology; 2009 Apr; 251(1):166-74. PubMed ID: 19251940
[TBL] [Abstract][Full Text] [Related]
17. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
Willowson KP; Bailey EA; Bailey DL
Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
20. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial.
Larke FJ; Kruger RL; Cagnon CH; Flynn MJ; McNitt-Gray MM; Wu X; Judy PF; Cody DD
AJR Am J Roentgenol; 2011 Nov; 197(5):1165-9. PubMed ID: 22021510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
